A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19
Clinical trial NCT04558021 · UNKNOWN
Trial details
- NCT number
- NCT04558021
- Sponsor
- Imuneks Farma ilac San. Tic. A.S.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2021-01-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.